Terms: = Cervical cancer AND FOXA1, TCF3A, 3169, ENSG00000129514, P55317, HNF3A, MGC33105
15 results:
1. Impact of HPV strains on molecular mechanisms of cervix cancer.
Sharma S; Chauhan D; Kumar S; Kumar R
Microb Pathog; 2024 Jan; 186():106465. PubMed ID: 38036109
[TBL] [Abstract] [Full Text] [Related]
2. High-grade and low-grade HPV-induced urethral lesions treated by CO
Aynaud O; Huynh B; Bergeron C
Sex Transm Infect; 2023 Jun; 99(4):279-282. PubMed ID: 36990695
[TBL] [Abstract] [Full Text] [Related]
3. Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study.
Wang G; Huang C; Yang K; Guo R; Qiu Y; Li W; Mao Y; Tang L; Ma J
Radiother Oncol; 2022 Dec; 177():205-213. PubMed ID: 36375564
[TBL] [Abstract] [Full Text] [Related]
4. foxa1 Leads to Aberrant Expression of SIX4 Affecting cervical cancer Cell Growth and Chemoresistance.
Wang Z; Sun BS; Chen ZS; Zhao KK; Wang YL; Meng FX; Zhang Y
Anal Cell Pathol (Amst); 2022; 2022():9675466. PubMed ID: 35498155
[TBL] [Abstract] [Full Text] [Related]
5. LINC00662 modulates cervical cancer cell proliferation, invasion, and apoptosis via sponging miR-103a-3p and upregulating PDK4.
Liu Y; Qiu S; Zheng X; Qiu Y; Yao S; Ge Y; Zhou C
Mol Carcinog; 2021 Jun; 60(6):365-376. PubMed ID: 33819358
[TBL] [Abstract] [Full Text] [Related]
6. An SGLT2 inhibitor modulates SHH expression by activating AMPK to inhibit the migration and induce the apoptosis of cervical carcinoma cells.
Xie Z; Wang F; Lin L; Duan S; Liu X; Li X; Li T; Xue M; Cheng Y; Ren H; Zhu Y
Cancer Lett; 2020 Dec; 495():200-210. PubMed ID: 32931885
[TBL] [Abstract] [Full Text] [Related]
7. Identifying cancer Screening Adherence in the Emergency Department Utilizing Research Associates.
Abar B; Dalawari P; Ogedegbe C; Santoro-Terray L; Adler D; Bradley K
J Emerg Med; 2020 Dec; 59(6):894-899. PubMed ID: 32843249
[TBL] [Abstract] [Full Text] [Related]
8. Identification of human papillomavirus type 16 variants circulating in the Calabria region by sequencing and phylogenetic analysis of HPV16 from cervical smears.
Galati L; Equestre M; Bruni R; Accardi L; Torti C; Fiorillo MT; Surace G; Barreca GS; Liberto MC; Focà A; Ciccaglione AR; Di Bonito P
Infect Genet Evol; 2019 Mar; 68():185-193. PubMed ID: 30578936
[TBL] [Abstract] [Full Text] [Related]
9. Effects of forkhead Box protein A1 on cell proliferation regulating and EMT of cervical carcinoma.
Gu F; Li ZH; Wang CQ; Yuan QF; Yan ZM
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7189-7196. PubMed ID: 30468461
[TBL] [Abstract] [Full Text] [Related]
10. Genetic variability and functional implication of the long control region in HPV-16 variants in Southwest China.
Xi J; Chen J; Xu M; Yang H; Luo J; Pan Y; Wang X; Qiu L; Yang J; Sun Q
PLoS One; 2017; 12(8):e0182388. PubMed ID: 28767682
[TBL] [Abstract] [Full Text] [Related]
11. foxa1 in HPV associated carcinomas: Its expression in carcinomas of the head and neck and of the uterine cervix.
Karpathiou G; Da Cruz V; Casteillo F; Mobarki M; Dumollard JM; Chauleur C; Forest F; Prades JM; Peoc'h M
Exp Mol Pathol; 2017 Apr; 102(2):230-236. PubMed ID: 28209524
[TBL] [Abstract] [Full Text] [Related]
12. Identification of novel cellular transcription factors that regulate early promoters of human papillomavirus types 18 and 16.
Sichero L; Sobrinho JS; Villa LL
J Infect Dis; 2012 Sep; 206(6):867-74. PubMed ID: 22740717
[TBL] [Abstract] [Full Text] [Related]
13. [Surgical treatment of esophageal carcinoma with cervical esophagogastrostomy by left thoracic esophagectomy].
Chen MY; Gao ZR; Xu JL; Wu S
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):301-3. PubMed ID: 19563704
[TBL] [Abstract] [Full Text] [Related]
14. cancer screening before and after switching to a high-deductible health plan.
Wharam JF; Galbraith AA; Kleinman KP; Soumerai SB; Ross-Degnan D; Landon BE
Ann Intern Med; 2008 May; 148(9):647-55. PubMed ID: 18458277
[TBL] [Abstract] [Full Text] [Related]
15. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
Kornovski Y; Gorchev G
J BUON; 2007; 12(1):57-63. PubMed ID: 17436403
[TBL] [Abstract] [Full Text] [Related]
